Table V.
Univariate Cox-regression analysis of clinicopathological characteristics in patients with endometrial adenocarcinoma.
| Clinicopathological characteristics | 95% Confidence interval | P-value | Hazard ratio |
|---|---|---|---|
| Age | 0.173–1.482 | 0.214 | −0.680 |
| ≤60 | |||
| >60 | |||
| FIGO stage | 1.598–7.66 | 0.006b | 1.670 |
| I–II | |||
| III | |||
| Grade | 0.597–8.244 | 0.234 | 0.797 |
| G1/G2 | |||
| G3 | |||
| Myometrial invasion | 1.547–3.228 | 0.006b | 1.509 |
| <50% | |||
| ≥50% | |||
| Lymph node metastasis | 1.750–7.236 | 0.004b | 1.703 |
| No | |||
| Yes | |||
| BMI-1 expression | 1.076–2.617 | 0.040a | 1.596 |
| Low | |||
| High |
a
P<0.05
b
P<0.01. BMI-1, B-lymphoma Mo-MLV insertion region 1; FIGO, International Federation of Gynecology and Obstetrics staging system.